在2型糖尿病的db/db小鼠模型中多omics对糖尿病病的表征
Liping Wang1, Ran Zhou1, Guanghui Li1
1Department of Pharmacy, Jing'an District Central Hospital of Shanghai, Fudan University, Shanghai, China & National Clinical Research Center for Eye Diseases, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
Computational and structural biotechnology journal
|August 13, 2025
概括
糖尿病病 (DN) 涉及超出血糖控制的代谢和脂质变化. 这项研究揭示了DN的关键分子通路和潜在的治疗点,突出了病的额外血糖驱动因素.
科学领域:
- 生物化学 生物化学
- 基因组学就是基因组学.
- 代谢学 代谢学 代谢学
- 利皮多米克 (Lipidomics) 是一种消化剂.
背景情况:
- 尽管得到了优化治疗,但糖尿病病 (DN) 仍存在残留风险.
- 独立于葡萄糖和血液动力学的病原性因素有助于DN.
- 了解这些因素对于有效的DN管理至关重要.
研究的目的:
- 为了研究DN病变的分子机制,超出葡萄糖代谢.
- 确定DN的新型治疗点.
- 在DN小鼠模型中进行脏组织的综合性多omics分析.
主要方法:
- 在db/db小鼠脏组织上进行综合性多omics分析 (转录组学,代谢组学,脂组学).
- 坐标投影到潜结构差异分析 (OPLS-DA) 用于代谢干扰的识别.
- 双向O2PLS用于代谢-转录组相关性和LINEX2用于脂质网络重建.
主要成果:
- 通过转录学识别的代谢和脂质通路的广泛失调.
- 甘氨酸-氨酸-氨酸代谢显著受到干扰,GLUL作为关键调节剂.
- 卡迪奥利平和等离子体样本的异常;与*chpt1*失调和减少组织再生相关的素胆生物合成受损.
结论:
- 多omics方法系统地划分DN分子景观.
- 在DNA中发现了被低估的代谢和脂质失调模式.
- 确定了DN管理的额外血糖驱动因素和潜在的治疗目标.
相关概念视频
Mouse Models of Cancer Study
4.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
4.7K
Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28


